This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neurophysiological Mechanisms of Language Comprehension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05283265
Recruitment Status : Recruiting
First Posted : March 16, 2022
Last Update Posted : March 25, 2024
Sponsor:
Collaborator:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Information provided by (Responsible Party):
Matthew J. Nelson, University of Alabama at Birmingham

Brief Summary:

First, in a recording-only self-paced reading experiment, patients with epilepsy undergoing intracranial monitoring for clinical purposes will read or listen to sentences presented to them one word at time while the investigators simultaneously record neural activity through intracranial electrodes that are implanted for clinical purposes (see subject populations). At the end of the sentence, the subjects have to indicate how they comprehended the sentence by selecting which of several pictures matches the sentence they just read. Behavioral measures that the investigators record and analyze are their response times to advance to each next word in the sentence, and which picture they chose for each sentence. These behavioral measures are compared against the neural activity simultaneously recorded as they are made.

Then, in a later session, the same participants will participate in a task-related stimulation experiment. This follows the exact same design as the recording-only reading experiment, the only difference is that on some trials, at controlled moments during the sentence presentation intracranial electrical stimulation is delivered through adjacent intracranial electrode contacts. The investigators will examine the effect of this stimulation on the subjects comprehension of the sentences measured by their behavior, and on the simultaneously recorded neural activity.


Condition or disease Intervention/treatment Phase
Language Disorders Behavioral: Sentence Type Other: Direct brain stimulation Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 153 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Neurophysiological Mechanisms of Language Comprehension
Actual Study Start Date : April 8, 2022
Estimated Primary Completion Date : October 8, 2026
Estimated Study Completion Date : October 8, 2026

Arm Intervention/treatment
Experimental: Intracranial patients
All participants with epilepsy undergoing intracranial monitoring for clinical purposes will be approached to participate in an experiment that is recording-only and an experiment that involves stimulation with simultaneous recording.
Behavioral: Sentence Type
Subjects read different types of sentences (object-relative, subject -relative and control sentences) to observe how that sentence affects their intracranially recorded neural activity.

Other: Direct brain stimulation
On some trials the investigators will apply intracranial electrical current through the electrodes implanted in the participants and observe the effect this has on their behavior (which picture they choose at the end of the trial) and the effect this has on their neural activity that the investigators record simultaneously through-out the experiment.
Other Name: Intracranial stimulation




Primary Outcome Measures :
  1. Behavioral Response- Picture Choice [ Time Frame: Measured immediately after the intervention ]
    The investigators will observe which picture the participant chooses at the end of each trial. The participant's choice will be measured by a touch screen that the patient touches to make their choice. The unit of measurement is the percentage of trials per condition studied in which participants choose the correct picture, versus the percentage of trials per condition studied in which participants choose the picture that reflects a patient-agent error (which reflects incorrect assignment of the patient versus agent roles of the nouns in the sentence), versus the percentage of trials per condition studied in which participants choose the picture that reflects a complement error (which reflects that the subjects mistakenly applied an adjective to the wrong noun in the sentence), versus the percentage of trials per condition studied in which participants choose the picture that reflects both a patient-agent and a complement error.

  2. Behavioral Response - Self-paced word response time for words presented before electrical stimulation [ Time Frame: Outcomes will be measured immediately before the intervention ]
    While subjects perform self-paced reading experiments, this is the amount of time they spend on each word of the sentence before moving on to the next word of the sentence.

  3. Behavioral Response - Self-paced word response time for words presented concomitant with electrical stimulation [ Time Frame: Outcomes will be measured concomitant with the intervention ]
    While subjects perform self-paced reading experiments, this is the amount of time they spend on each word of the sentence before moving on to the next word of the sentence.

  4. Behavioral Response - Self-paced word response time for words presented after electrical stimulation [ Time Frame: Outcomes will be measured immediately after the intervention ]
    While subjects perform self-paced reading experiments, this is the amount of time they spend on each word of the sentence before moving on to the next word of the sentence, for words presented after electrical stimulation

  5. Neural activation before electrical stimulation [ Time Frame: Outcomes will be measured immediately before the intervention ]
    With the electrodes implanted in the patient as a standard of care, the investigators will measure the neural activation at each electrode as assessed by the high gamma power present in that recorded channel

  6. Neural activation concomitant with electrical stimulation [ Time Frame: Outcomes will be measured concomitant with the intervention ]
    With the electrodes implanted in the patient as a standard of care, the investigators will measure the neural activation at each electrode as assessed by the high gamma power present in that recorded channel

  7. Neural activation after electrical stimulation [ Time Frame: Outcomes will be measured immediately after the intervention ]
    With the electrodes implanted in the patient as a standard of care, the investigators will measure the neural activation at each electrode as assessed by the high gamma power present in that recorded channel



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 18 and older
  • Undergoing standard of care stereo Electro Encephalogram (sEEG) or Electro-Corticogram (ECoG) monitoring
  • Able to competently perform control trials of the task

Exclusion Criteria:

  • Age less than 18 years
  • Unable to competently perform control trials of the task

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05283265


Contacts
Layout table for location contacts
Contact: Matthew Nelson, PhD 2059346717 matthewnelson@uabmc.edu

Locations
Layout table for location information
United States, Alabama
The University of Alabama at Birmingham Hospital Recruiting
Birmingham, Alabama, United States, 35294
Contact: Matthew Nelson, MD    205-934-6717    matthewnelson@uabmc.edu   
Sponsors and Collaborators
University of Alabama at Birmingham
National Institute on Deafness and Other Communication Disorders (NIDCD)
Investigators
Layout table for investigator information
Principal Investigator: Matthew Nelson, PhD The University of Alabama at Birmingham
Additional Information:
Publications:

Layout table for additonal information
Responsible Party: Matthew J. Nelson, Assistant Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT05283265    
Other Study ID Numbers: IRB-300008888
5K01DC019165 ( U.S. NIH Grant/Contract )
First Posted: March 16, 2022    Key Record Dates
Last Update Posted: March 25, 2024
Last Verified: March 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: After publication of the main results, limited access datasets that are free of identifying information will be made available to the scientific community per NIH guidelines in accordance with UAB policies and state and federal regulations. The final dataset will be stripped of identifying information before sharing.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: Data will be made available for a period of 10 years starting 6 months after publication.
Access Criteria: All researchers who seek data will be asked to commit to protect privacy and confidentiality, secure the data using appropriate computer technology, refrain from redistributing data to third parties, and destroy or return the data after completion of analyses. The PI will review data sharing requests. Researchers requesting data may be asked to submit in writing a signed statement affirming their commitment to protect privacy and confidentiality.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Matthew J. Nelson, University of Alabama at Birmingham:
Neurophysiological
Language Comprehension
Direct brain stimulation
Self-paced reading
Additional relevant MeSH terms:
Layout table for MeSH terms
Language Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases